➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Mallinckrodt
McKinsey
Johnson and Johnson
Boehringer Ingelheim

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Lumicitabine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Lumicitabine?

Lumicitabine is an investigational drug.

There have been 6 clinical trials for Lumicitabine. The most recent clinical trial was a Phase 1 trial, which was initiated on November 16th 2017.

The most common disease conditions in clinical trials are Virus Diseases, Respiratory Syncytial Virus Infections, and Respiratory Sounds. The leading clinical trial sponsors are Janssen Research & Development, LLC, Janssen Pharmaceutica N.V., Belgium, and [disabled in preview].

There are ten US patents protecting this investigational drug and one hundred and fifty-four international patents.

Recent Clinical Trials for Lumicitabine
TitleSponsorPhase
Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human MetapneumovirusJanssen Research & Development, LLCPhase 2
A Crossover Study to Assess the Drug-drug Interaction of Acid Reducing Agent(s) on the Pharmacokinetics of a Single Oral Dose of Lumicitabine (JNJ-64041575) in Healthy Adult ParticipantsJanssen Research & Development, LLCPhase 1
A Crossover Study to Assess the Effect of Intravenous Infusion of Piperacillin/Tazobactam on the Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) in Healthy Adult ParticipantsJanssen Research & Development, LLCPhase 1

See all Lumicitabine clinical trials

Clinical Trial Summary for Lumicitabine

Top disease conditions for Lumicitabine
Top clinical trial sponsors for Lumicitabine

See all Lumicitabine clinical trials

US Patents for Lumicitabine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lumicitabine   Try Before You Buy RSV antiviral pyrazolo- and triazolo-pyrimidine compounds Janssen Sciences Ireland UC (Little Island, Co Cork, IE)   Try Before You Buy
Lumicitabine   Try Before You Buy Antiviral compounds Alios BioPharma, Inc. (South San Francisco, CA)   Try Before You Buy
Lumicitabine   Try Before You Buy Methods of preparing substituted nucleoside analogs ALIOS BIOPHARMA, INC. (South San Francisco, CA)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Lumicitabine

Drugname Country Document Number Estimated Expiration Related US Patent
Lumicitabine Argentina AR104422 2035-04-28   Try Before You Buy
Lumicitabine Australia AU2016254700 2035-04-28   Try Before You Buy
Lumicitabine Brazil BR112017023263 2035-04-28   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Colorcon
Express Scripts
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.